Literature DB >> 2111107

Increased lung epithelial permeability in HIV-infected patients with isolated cytotoxic T-lymphocytic alveolitis.

M Meignan1, J M Guillon, M Denis, P Joly, J Rosso, M F Carette, L Baud, F Parquin, F Plata, P Debre.   

Abstract

HIV-related lymphocytic alveolitis is common in HIV-seropositive patients without lung infection or tumor. In some of them a fraction of alveolar lymphocytes are HIV-specific cytotoxic T-lymphocytes (CTL) bearing the CD8 and D44 cell surface markers and capable of killing HIV-infected alveolar macrophages. In order to evaluate the in vivo effect of these CTL on lung function, we measured the pulmonary clearance of aerosolized 99mTc-diethylene triamine penta-acetate (DTPA-CI) on 24 occasions in 22 patients with lymphocytic alveolitis. DTPA-CI has been selected as a highly sensitive test to detect injury of the lung epithelium. In 13 of the patients, we found a high DTPA-CI of 4.56 +/- 2.54%.min-1 (mean +/- SD), suggesting an increase of the epithelial permeability. The lymphocytic alveolitis was then characterized by a high cellularity, a high proportion of lymphocytes (59 +/- 18%), mainly composed of CD8+D44+ T-lymphocytes (149 +/- 109 cells/mm3), which spontaneously exhibited a cytolytic activity against the autologous alveolar macrophages in a standard 51Cr release assay. In the remaining 11 patients, DTPA-CI was normal (less than 1.78%.min-1), lymphocytic alveolitis being characterized by a low number or an absence of CD8+D44+ alveolar lymphocytes (9 +/- 13 cells/mm3) with no significant cytolytic activity. In the whole group, a significant correlation (r = 0.74, p = 0.0004) was found between the DTPA-CI and the number of CD8+D44+ lymphocytes and their cytotoxic activity against alveolar macrophages. Altogether, these results suggest that an injury of the lung epithelium could result from a HIV-specific CTL-induced immunologic conflict.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2111107     DOI: 10.1164/ajrccm/141.5_Pt_1.1241

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  8 in total

Review 1.  AIDS and the lung: update 1995. 4. Role of the human immunodeficiency virus within the lung.

Authors:  J R Clarke; D S Robinson; R J Coker; R F Miller; D M Mitchell
Journal:  Thorax       Date:  1995-05       Impact factor: 9.139

2.  HIV in the lung: guilty or not guilty?

Authors:  C M Mayaud; J Cadranel
Journal:  Thorax       Date:  1993-12       Impact factor: 9.139

3.  Does analysis of bronchoalveolar lavage fluid provide a tool to monitor disease progression or to predict survival in patients with HIV-1 infection?

Authors:  C Agostini; G Semenzato
Journal:  Thorax       Date:  1994-09       Impact factor: 9.139

4.  Cytotoxicity for lung epithelial cells is a virulence-associated phenotype of Mycobacterium tuberculosis.

Authors:  K A McDonough; Y Kress
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

5.  Arterial desaturation in HIV positive patients undergoing sputum induction.

Authors:  R F Miller; J Buckland; S J Semple
Journal:  Thorax       Date:  1991-06       Impact factor: 9.139

6.  Ovine lentivirus expression and disease. Virus replication, but not entry, is restricted to macrophages of specific tissues.

Authors:  S J Brodie; L D Pearson; M C Zink; H M Bickle; B C Anderson; K A Marcom; J C DeMartini
Journal:  Am J Pathol       Date:  1995-01       Impact factor: 4.307

7.  HIV Impairs Lung Epithelial Integrity and Enters the Epithelium to Promote Chronic Lung Inflammation.

Authors:  Kieran A Brune; Fernanda Ferreira; Pooja Mandke; Eric Chau; Neil R Aggarwal; Franco R D'Alessio; Allison A Lambert; Gregory Kirk; Joel Blankson; M Bradley Drummond; Athe M Tsibris; Venkataramana K Sidhaye
Journal:  PLoS One       Date:  2016-03-01       Impact factor: 3.240

8.  Dysregulation of the Immune Environment in the Airways During HIV Infection.

Authors:  Rubina Bunjun; Andreia P Soares; Narjis Thawer; Tracey L Müller; Agano Kiravu; Zekarias Ginbot; Björn Corleis; Brandon D Murugan; Douglas S Kwon; Florian von Groote-Bidlingmaier; Catherine Riou; Robert J Wilkinson; Gerhard Walzl; Wendy A Burgers
Journal:  Front Immunol       Date:  2021-06-30       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.